First Manhattan’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Hold |
0
| – | – | – | 1696 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 1700 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 1718 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 1715 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 1718 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 1649 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 1584 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 1436 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 1498 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 1502 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 1485 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 1393 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 1423 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 1464 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 1478 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 1462 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 1465 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 1445 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 1484 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 1545 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 1520 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 1491 |
|
2017
Q1 | – | Sell |
-1
| Closed | – | – | 1472 |
|
2016
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1465 |
|
2016
Q3 | $0 | Sell |
1
-1
| -50% | – | ﹤0.01% | 1479 |
|
2016
Q2 | $3K | Hold |
2
| – | – | ﹤0.01% | 1383 |
|
2016
Q1 | $2K | Hold |
2
| – | – | ﹤0.01% | 1341 |
|
2015
Q4 | $2K | Hold |
2
| – | – | ﹤0.01% | 1355 |
|
2015
Q3 | $3K | Hold |
2
| – | – | ﹤0.01% | 1322 |
|
2015
Q2 | $4K | Hold |
2
| – | – | ﹤0.01% | 1328 |
|
2015
Q1 | $6K | Hold |
2
| – | – | ﹤0.01% | 1287 |
|
2014
Q4 | $7K | Hold |
2
| – | – | ﹤0.01% | 1290 |
|
2014
Q3 | $6K | Hold |
2
| – | – | ﹤0.01% | 1282 |
|
2014
Q2 | $7K | Hold |
2
| – | – | ﹤0.01% | 1243 |
|
2014
Q1 | $7K | Hold |
2
| – | – | ﹤0.01% | 1234 |
|
2013
Q4 | $7K | Hold |
2
| – | – | ﹤0.01% | 1206 |
|
2013
Q3 | $7K | Hold |
2
| – | – | ﹤0.01% | 1207 |
|
2013
Q2 | $20K | Buy |
+2
| New | +$20K | ﹤0.01% | 1070 |
|